Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
48 studies found for:    502-201
Show Display Options
Rank Status Study
1 Completed A Study of ARRY-502 in Patients With Persistent Asthma
Condition: Asthma
Interventions: Drug: ARRY-502, CRTh2 antagonist; oral;   Drug: Placebo; oral
2 Completed
Has Results
Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Conditions: Meningitis;   Meningococcal Infection
Interventions: Biological: MenACWY-CRM197;   Biological: DTaP (Diptheria, Tetanus, Pertussis) Vaccine;   Biological: Hib (Haemophilus influenza b) Vaccine;   Biological: IPV (Inactivated Polio Vaccine) Vaccine;   Biological: Pneumococcal conjugate Vaccine;   Biological: MMR (Measles, Mumps, and Rubella) Vaccine;   Biological: Varicella Vaccine;   Biological: Hepatitis A Virus
3 Completed Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
Condition: Epilepsy
Intervention: Drug: Brivaracetam
4 Completed
Has Results
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Conditions: Restless Legs Syndrome;   End-Stage Renal Disease
Interventions: Drug: Rotigotine;   Drug: Placebo
5 Active, not recruiting Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy
Condition: Epilepsy
Intervention: Drug: Brivaracetam
6 Active, not recruiting Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy
Condition: Epilepsy
Intervention: Drug: Brivaracetam
7 Enrolling by invitation Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy
Condition: Epilepsy
Intervention: Drug: Brivaracetam (BRV)
8 Completed
Has Results
Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV
Condition: Peripheral Arterial Occlusive Disease
Interventions: Drug: Alprostadil;   Other: Placebo
9 Terminated A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke
Condition: Acute Ischaemic Middle Cerebral Artery Stroke
Interventions: Drug: Piracetam;   Other: Placebo
10 Recruiting Aplidin - Dexamethasone in Relapsed/Refractory Myeloma
Condition: Relapsed/Refractory Multiple Myeloma
Interventions: Drug: plitidepsin + dexamethasone;   Drug: dexamethasone
11 Active, not recruiting
Has Results
Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis
Condition: Spondyloarthropathies
Interventions: Biological: CZP 200 mg Q2W;   Biological: CZP 400 mg Q4W;   Other: Placebo
12 Completed Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
Condition: Epilepsy
Intervention: Drug: Brivaracetam
13 Completed
Has Results
A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease
Condition: Advanced Parkinson's Disease
Intervention: Drug: Rotigotine
14 Completed Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures
Condition: Epilepsy
Interventions: Drug: Placebo;   Drug: Brivaracetam
15 Completed
Has Results
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
Condition: Influenza
Interventions: Drug: Favipiravir;   Drug: Placebo comparator
16 Completed
Has Results
Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
Conditions: Advanced Prostate Cancer;   Lower Urinary Tract Symptoms
Intervention: Drug: Leuprolide acetate Depot Susp. 11.25 mg (Poland), 3.75 mg (Ukraine)
17 Completed Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch
Conditions: Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN);   or Peripheral Nerve Injury (PNI)
Interventions: Drug: QUTENZA;   Drug: Lidocaine;   Drug: Tramadol
18 Completed Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
Condition: Cardiovascular Diseases
Interventions: Drug: Fenofibrate/Simvastatin;   Drug: Simvastatin
19 Active, not recruiting Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 4 Years Old
Condition: Influenza
Intervention: Biological: TIV
20 Completed Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
Condition: Hyperlipidemia
Interventions: Drug: Fenofibrate/Simvastatin;   Drug: Simvastatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years